trending Market Intelligence /marketintelligence/en/news-insights/trending/hjwtlf2pipfsk4asukz0ba2 content esgSubNav
In This List

OncoSec Medical plans common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


OncoSec Medical plans common stock offering

OncoSec Medical Inc. plans to sell its common shares in an underwritten public offering.

The company plans to grant the underwriters an option to buy up to an additional 15% of the shares offered.

OncoSec plans to use the net proceeds primarily for a phase 2 trial in skin cancer, for other clinical and research and development activities, and for working capital and general corporate purposes.

Piper Jaffray & Co. is acting as lead book-running manager for the offering. Cantor Fitzgerald & Co. is also acting as a book runner.